Modern therapy with interferonogens for acute respiratory viral infections in children

The article presents data on the place of the modern endogenous interferon inducers in the treatment and prevention of influenza and ARVI in children and the mechanisms of action. The focus is on the domestic antiviral agents Kagocel which demonstrated high clinical efficacy and safety in multi-center, blind, placebo-controlled studies involving treatment and prevention of ARVI/flu in children over 2 years old